We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bir üniversite hastanesi endokrinoloji kliniğinde eksenatid verilen hastaların klinik ve laboratuvar özellikleri.
- Authors
Kılınç1, Faruk; Alpağat, Gülistan; Demircan, Fatih; Pekkolay, Zafer; Gözel, Nevzat; Tuzcu, Alpaslan Kemal
- Abstract
Objective: Exenatide has high affinity on binding GLP - 1 receptors. Endogenous GLP - 1 effects glucose -dependent insulin secretion, delayed gastric emptying, suppression of glucagon, inhibition of appetite, and shows effects of enhancing β - cell mass. It is usually use in the treatment of type 2 obese diabetic patients, whose treatment not be obtained with metformin and sulfonylurea or both. It was added to insulin therapy, because it provides better glycemic control and weight loss in cases which have high level of blood glucose with oral antidiabetic. In our study we planned to share the patients treated with exenatide in our clinic for a period of at least 4 months and discuss their biochemical and clinical parameters. Methods: In this study we evaluated 26 patients (2 males, 24 females) who admitted our clinic between July 2011 and December 2013 and who followed up at least 4 months (mean: 7.3) All of the patients were using metformin in combination with oral antidiabetic drug therapy, while 6 patients were receiving insulin therapy in addition to metformin. Results: After treatment, HemoglobineA1c decrease were found 0.98 % for women and 1.4% for men and of weight loss were found 0.64% for women and 0.57% for men, measurements of body mass index were decreased 0.61% for females and 0.56% for men. Conclusion: We determined that; addition of exenatide treatment to Insulin, metformin or oral antidiabetic therapy combination in obese patients leads to weight loss and decrease Hemoglobin A1c levels.
- Publication
Dicle Medical Journal / Dicle Tip Dergisi, 2014, Vol 41, Issue 1, p128
- ISSN
1300-2945
- Publication type
Article
- DOI
10.5798/diclemedj.0921.2014.01.0386